Novartis AG (SWX: NOVN)

Novartis AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	48,587	45,440	42,206	42,781	48,659	47,498
Other Revenue	1,353	1,220	1,255	1,193	1,239	1,179
Revenue	49,940	46,660	43,461	43,974	49,898	48,677
Revenue Growth (YoY)	8.92%	7.36%	-1.17%	-11.87%	2.51%	5.59%
Cost of Revenue	12,071	12,020	11,297	11,391	15,121	14,425
Gross Profit	37,869	34,640	32,164	32,583	34,777	34,252
Selling, General & Admin	12,479	12,489	12,143	12,756	14,197	14,369
Research & Development	7,146	9,011	8,425	8,259	8,980	9,402
Other Operating Expenses	-78	498	387	605	1,448	1,395
Operating Expenses	19,547	21,998	20,955	21,620	24,625	25,166
Operating Income	18,322	12,642	11,209	10,963	10,152	9,086
Interest Expense	-948	-855	-800	-787	-869	-850
Interest & Investment Income	627	627	377	70	91	245
Earnings From Equity Investments	-41	-13	-11	15,337	673	659
Currency Exchange Gain (Loss)	-214	-214	-184	-69	-135	-160
Other Non Operating Income (Expenses)	-80	17	-53	-39	-34	-40
EBT Excluding Unusual Items	17,666	12,204	10,538	25,475	9,878	8,940
Merger & Restructuring Charges	-964	-951	-1,822	-827	-	-
Gain (Loss) on Sale of Investments	-49	-105	-260	38	-	-
Gain (Loss) on Sale of Assets	49	225	166	724	-	-
Asset Writedown	-4,091	-3,088	-1,664	-619	-	-
Legal Settlements	-	542	-313	-170	-	-
Other Unusual Items	121	296	532	-91	-	-
Pretax Income	12,732	9,123	7,177	24,530	9,878	8,940
Income Tax Expense	975	551	1,128	1,625	1,807	1,793
Earnings From Continuing Operations	11,757	8,572	6,049	22,905	8,071	7,147
Earnings From Discontinued Operations	5,842	6,282	906	1,113	-	4,590
Net Income to Company	17,599	14,854	6,955	24,018	8,071	11,737
Minority Interest in Earnings	4	-4	-	3	1	-5
Net Income	17,603	14,850	6,955	24,021	8,072	11,732
Net Income to Common	17,603	14,850	6,955	24,021	8,072	11,732
Net Income Growth	124.64%	113.52%	-71.05%	197.58%	-31.20%	-6.97%
Shares Outstanding (Basic)	2,035	2,077	2,181	2,243	2,277	2,291
Shares Outstanding (Diluted)	2,052	2,092	2,197	2,260	2,296	2,319
Shares Change (YoY)	-2.91%	-4.78%	-2.79%	-1.57%	-0.99%	-1.07%
EPS (Basic)	8.65	7.15	3.19	10.71	3.54	5.12
EPS (Diluted)	8.58	7.10	3.17	10.63	3.52	5.06
EPS Growth	130.53%	123.90%	-70.16%	202.06%	-30.43%	-5.97%
Free Cash Flow	14,759	13,398	13,320	14,005	12,375	12,246
Free Cash Flow Per Share	7.19	6.40	6.06	6.20	5.39	5.28
Dividend Per Share	3.919	3.919	3.461	3.401	3.391	3.120
Dividend Growth	13.24%	13.24%	1.77%	0.29%	8.68%	9.86%
Gross Margin	75.83%	74.24%	74.01%	74.10%	69.70%	70.37%
Operating Margin	36.69%	27.09%	25.79%	24.93%	20.35%	18.67%
Profit Margin	35.25%	31.83%	16.00%	54.63%	16.18%	24.10%
Free Cash Flow Margin	29.55%	28.71%	30.65%	31.85%	24.80%	25.16%
EBITDA	20,985	17,518	15,936	15,633	14,932	13,267
EBITDA Margin	42.02%	37.54%	36.67%	35.55%	29.93%	27.26%
D&A For EBITDA	2,663	4,876	4,727	4,670	4,780	4,181
EBIT	18,322	12,642	11,209	10,963	10,152	9,086
EBIT Margin	36.69%	27.09%	25.79%	24.93%	20.35%	18.67%
Effective Tax Rate	7.66%	6.04%	15.72%	6.62%	18.29%	20.06%

Source: S&P Capital IQ. Standard template. Financial Sources.